Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemiaAnnalisa Ruggeri, Mohamad Mohty, Jaime Sanz et al.|Leukemia|2015Cited by 216
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patientsAlexandros Spyridonidis, Mohamad Mohty, Myriam Labopin et al.|Bone Marrow Transplantation|2020Cited by 202
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantationStefan O. Ciurea, Arnon Nagler, Monzr M. Al Malki et al.|Bone Marrow Transplantation|2019Cited by 161
Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMTMohamad Mohty, Jaime Sanz, Jacques‐Emmanuel Galimard et al.|Journal of Hematology & Oncology|2020Cited by 117
Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective studyHouli Zhao, Yongxian Hu, Jieping Wei et al.|Journal of Hematology & Oncology|2020Cited by 82